Philip Bedford

Health Technology

Profile

Philip Bedford worked as a Non-Executive Director at Adjuvantix Ltd.
and as a Senior Head-Clinical Programme at Glaxo Wellcome Plc in 1997.
He also worked as a Senior VP-Clinical Operations & Regulatory Affairs at Acambis Plc.

Former positions of Philip Bedford

Companies	Position	End
Glaxo Wellcome Plc	Corporate Officer/Principal	31/12/1996
Acambis Plc Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.	Chief Tech/Sci/R&D Officer	-
Adjuvantix Ltd. Adjuvantix Ltd. BiotechnologyHealth Technology Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom.	Director/Board Member	-

See the detail of Philip Bedford's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies